I first heard about Dr Joseph Fraiman in the second half of September 2021 following the testimony he gave to the FDA’s advisory committee on vaccines and related biological products of 17th September (https://youtu.be/WFph7-6t34M?t=15418; or here) about vaccine hesitancy being based on legitimate concerns.
Today (9th January 2023), Dr Fraiman uploaded a short clip on to his Rumble account in which he voices his concerns about the excess mortality rates which have been recorded in many countries following the mRNA vaccination and booster campaigns and in which he recommends that the vaccines be withdrawn from the market.
If the clip does not play in ‘picture-in-picture’ mode after a right click with your mouse, then click on https://sp.rmbl.ws/s8/2/A/m/J/Q/AmJQh.caa.mp4.
Original source
https://rumble.com/v24k8be-its-time-to-withdraw-the-mrna-vaccines.html
Hello, my name is Doctor Joseph Fraiman. I’m an emergency physician based in Louisiana. In addition, I am a clinical scientist. I was the lead author of the peer reviewed study that re-analysed the original Pfizer and Moderna clinical trials for the messenger RNA COVID-19vaccines. We found the vaccine increased serious adverse events at a rate of 1 in 800. At the time of publication, my co-authors and I did not believe our single study warranted the withdrawal of the messenger RNA vaccines from the market. However, since its publication, multiple new pieces of evidence have come to light and this has caused me to re-evaluate my position. An article published in the BMJ regarding the FDA’s own observational surveillance data found the messenger RNAs were associated with multiple of the exact same serious adverse events identified in our original study. But the FDA had failed to inform the public of these findings. In addition, now we have multiple autopsy studies that find essentially conclusive evidence that the vaccines are inducing sudden cardiac deaths; yet the rate of these vaccine induced deaths remains unknown. While many nations that have been using the messenger RNA vaccines have experienced an increase in excess mortality, more people dying than should be expected from past years. And this correlates in time with the initial vaccine rollout and then with the subsequent booster campaigns. Nations with higher messenger RNA vaccine uptake have correlations with higher rates of excess mortality. While the cause of this excess mortality is not known, researchers analysing these data were unable to identify any other reasonable cause of the excess death other than the vaccines. Given now that [the] Omicron variant is less virulent and is able to evade much of the protection offered by the vaccines, this creates a situation where the benefits of the vaccine have been dramatically reduced in … for hospitalisation and death. Together, this information calls into question if the vaccines benefits are outweighing the harm. I believe, given the information, the messenger RNA vaccines need to be withdrawn from the market until new randomised control trials can clearly demonstrate the benefits of the vaccine outweigh the serious harm we now know the vaccines are causing.
Bibliography provided by Dr Joseph Fraiman:
Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine, 40(40), 5798-5805.
https://pubmed.ncbi.nlm.nih.gov/36055877/
Demasi, M. (2022). FDA oversight of clinical trials is “grossly inadequate,” say experts. bmj, 379. Wong HL, Zhou CK, Tworkoski E, et al. Assessment of acute myocardial infarction, pulmonary embolism, disseminated intravascular coagulation and immune thrombocytopenia following covid-19 vaccination. FDA, Center for Biologics Evaluation and Research, Office of Biostatistics and Epidemiology. 2021.
https://bestinitiative.org/wp-content/uploads/2021/09/C-19-Vaccine-Safety-AMI-PE-DIC-ITP-Protocol-2021.pdf
Schneider J, Sottmann L, Greinacher A, Hagen M, Kasper HU, Kuhnen C, et al. Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. Int J Legal Med [Internet]. 2021 Nov;135(6):2335–45.
Available from: http://dx.doi.org/10.1007/s00414-021-02706-9
Sessa F, Salerno M, Esposito M, Di Nunno N, Zamboni P, Pomara C. Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. J Clin Med Res [Internet]. 2021 Dec 15;10(24).
Available from: http://dx.doi.org/10.3390/jcm10245876
Gill JR, Tashjian R, Duncanson E. Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the SecondCOVID-19 Vaccine Dose. Arch Pathol Lab Med [Internet]. 2022 Aug 1;146(8):925–9.
Available from: http://dx.doi.org/10.5858/arpa.2021-0435-SA
Schwab C, Domke LM, Hartmann L, Stenzinger A, Longerich T, Schirmacher P. Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination. Clin Res Cardiol [Internet]. 2022 Nov 27;1–10.
Available from: http://dx.doi.org/10.1007/s00392-022-02129-5
Fenton N, Neil M (2022) The Devil's Advocate: An Exploratory Analysis of 2022 Excess Mortality
https://wherearethenumbers.substack.com/p/the-devils-advocate-an-exploratory
Other links
https://twitter.com/JosephFraiman
[thread in relation to the above clip] https://twitter.com/JosephFraiman/status/1612394194672259072
FDA urged to publish follow-up studies on covid-19 vaccine safety signals
BMJ 2022; 379 doi: https://doi.org/10.1136/bmj.o2527 (Published 25 October 2022)
https://www.bmj.com/content/379/bmj.o2527
https://eu.usatoday.com/story/news/factcheck/2021/09/27/fact-check-fda-didnt-say-unvaccinated-people-more-educated/5850139001/
TRANSCRIPT
Hello, my name is Doctor Joseph Fraiman. I’m an emergency physician based in Louisiana. In addition, I am a clinical scientist. I was the lead author of the peer reviewed study that re-analysed the original Pfizer and Moderna clinical trials for the messenger RNA COVID-19vaccines. We found the vaccine increased serious adverse events at a rate of 1 in 800. At the time of publication, my co-authors and I did not believe our single study warranted the withdrawal of the messenger RNA vaccines from the market. However, since its publication, multiple new pieces of evidence have come to light and this has caused me to re-evaluate my position. An article published in the BMJ regarding the FDA’s own observational surveillance data found the messenger RNAs were associated with multiple of the exact same serious adverse events identified in our original study. But the FDA had failed to inform the public of these findings. In addition, now we have multiple autopsy studies that find essentially conclusive evidence that the vaccines are inducing sudden cardiac deaths; yet the rate of these vaccine induced deaths remains unknown. While many nations that have been using the messenger RNA vaccines have experienced an increase in excess mortality, more people dying than should be expected from past years. And this correlates in time with the initial vaccine rollout and then with the subsequent booster campaigns. Nations with higher messenger RNA vaccine uptake have correlations with higher rates of excess mortality. While the cause of this excess mortality is not known, researchers analysing these data were unable to identify any other reasonable cause of the excess death other than the vaccines. Given now that [the] Omicron variant is less virulent and is able to evade much of the protection offered by the vaccines, this creates a situation where the benefits of the vaccine have been dramatically reduced in … for hospitalisation and death. Together, this information calls into question if the vaccines benefits are outweighing the harm. I believe, given the information, the messenger RNA vaccines need to be withdrawn from the market until new randomised control trials can clearly demonstrate the benefits of the vaccine outweigh the serious harm we now know the vaccines are causing.
Bibliography provided by Dr Joseph Fraiman:
Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine, 40(40), 5798-5805.
https://pubmed.ncbi.nlm.nih.gov/36055877/
Demasi, M. (2022). FDA oversight of clinical trials is “grossly inadequate,” say experts. bmj, 379. Wong HL, Zhou CK, Tworkoski E, et al. Assessment of acute myocardial infarction, pulmonary embolism, disseminated intravascular coagulation and immune thrombocytopenia following covid-19 vaccination. FDA, Center for Biologics Evaluation and Research, Office of Biostatistics and Epidemiology. 2021.
https://bestinitiative.org/wp-content/uploads/2021/09/C-19-Vaccine-Safety-AMI-PE-DIC-ITP-Protocol-2021.pdf
Schneider J, Sottmann L, Greinacher A, Hagen M, Kasper HU, Kuhnen C, et al. Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. Int J Legal Med [Internet]. 2021 Nov;135(6):2335–45.
Available from: http://dx.doi.org/10.1007/s00414-021-02706-9
Sessa F, Salerno M, Esposito M, Di Nunno N, Zamboni P, Pomara C. Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. J Clin Med Res [Internet]. 2021 Dec 15;10(24).
Available from: http://dx.doi.org/10.3390/jcm10245876
Gill JR, Tashjian R, Duncanson E. Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the SecondCOVID-19 Vaccine Dose. Arch Pathol Lab Med [Internet]. 2022 Aug 1;146(8):925–9.
Available from: http://dx.doi.org/10.5858/arpa.2021-0435-SA
Schwab C, Domke LM, Hartmann L, Stenzinger A, Longerich T, Schirmacher P. Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination. Clin Res Cardiol [Internet]. 2022 Nov 27;1–10.
Available from: http://dx.doi.org/10.1007/s00392-022-02129-5
Fenton N, Neil M (2022) The Devil's Advocate: An Exploratory Analysis of 2022 Excess Mortality
https://wherearethenumbers.substack.com/p/the-devils-advocate-an-exploratory
Other links
https://twitter.com/JosephFraiman
[thread in relation to the above clip] https://twitter.com/JosephFraiman/status/1612394194672259072
FDA urged to publish follow-up studies on covid-19 vaccine safety signals
BMJ 2022; 379 doi: https://doi.org/10.1136/bmj.o2527 (Published 25 October 2022)
https://www.bmj.com/content/379/bmj.o2527
https://eu.usatoday.com/story/news/factcheck/2021/09/27/fact-check-fda-didnt-say-unvaccinated-people-more-educated/5850139001/
Lausanne, the above was
published on the ninth day of the first
month of the year two thousand and
twenty-three.
